Lennart von Fritsch

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Tobias Keck · 4 shared papers, 2024–2026 · strength 1.00
   • Paper [Innovations in the German Guideline for Pancreatic Cancer]. DOI 10.1055/a-2529-5372↗
   • Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
   • Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
2. Kim C. Honselmann · 4 shared papers, 2024–2026 · strength 1.00
   • Paper [Innovations in the German Guideline for Pancreatic Cancer]. DOI 10.1055/a-2529-5372↗
   • Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
   • Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
3. Hryhoriy V. Lapshyn · 3 shared papers, 2024–2026 · strength 0.58
   • Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
   • Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
   • Paper Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucin… DOI 10.3390/cancers16112016↗
4. Thaer S. A. Abdalla · 3 shared papers, 2024–2026 · strength 0.58
   • Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
   • Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
   • Paper Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucin… DOI 10.3390/cancers16112016↗
5. Louisa Bolm · 3 shared papers, 2024–2026 · strength 0.58
   • Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
   • Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
   • Paper Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucin… DOI 10.3390/cancers16112016↗
6. Rüdiger Braun · 3 shared papers, 2024–2026 · strength 0.58
   • Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
   • Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
   • Paper Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucin… DOI 10.3390/cancers16112016↗
7. Steffen Deichmann · 3 shared papers, 2024–2026 · strength 0.58
   • Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
   • Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
   • Paper Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucin… DOI 10.3390/cancers16112016↗
8. Ulrich Friedrich Wellner · 3 shared papers, 2024–2026 · strength 0.58
   • Paper Octogenarians and Pancreatic Cancer: Is Surgery Always the Right Choice? DOI 10.3390/cancers18152423↗
   • Paper An R0 resection margin does improve overall survival after PDAC resection- real-world evidence from 6.000 cases from th… DOI 10.1016/j.ejso.2025.109693↗
   • Paper Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucin… DOI 10.3390/cancers16112016↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.